HAVANA : Cuba's drug regulatory authority on Thursday approved a second COVID-19 vaccine candidate for late-stage clinical trials as the country races to secure a homegrown shot to quell its worst outbreak since the start of the pandemic and sell abroad.The Communist-run Caribbean island nation, which has long experience with developing and exporting vaccines, is one of a handful in the region that have not started vaccinating against COVID, as it is counting on its own candidates.
This month, Cuba started late-phase trials of its most advanced experimental vaccine, named Soberana (Sovereignty) 2, reflecting national pride in its relative self-reliance in areas like healthcare despite the decades-old U.S.